BackKissei Pharmaceutical , Ltd. Overview
Kissei Pharmaceutical Co., Ltd.

Kissei Pharmaceutical , Ltd. Return on Equity

Latest ROE for Kissei Pharmaceutical , Ltd.: 4.9% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

4.90%

Return on Equity

4.90%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Kissei Pharmaceutical , Ltd. (KSPHF) FAQ

The latest ROE for KSPHF is 4.9%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Kissei Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, KSPHF currently prints 4.9% for ROE, while the sector average sits near 11.3%. That is roughly 56.6% below the sector mean. Large gaps often invite a closer look at Kissei Pharmaceutical , Ltd.'s growth, margins, and balance sheet.

Return on Equity shows how effectively Kissei Pharmaceutical , Ltd. converts resources into returns. At 4.9%, KSPHF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting KSPHF's ROE (4.9%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.